the TARGET Consortium, Swinnen, E., Jansen, B., Degelaen, M., De Raedt, S., & Omelina, L. (2025). TARGET: A Major European Project Aiming to Advance the Personalised Management of Atrial Fibrillation-Related Stroke via the Development of Health Virtual Twins Technology and Artificial Intelligence. Thrombosis and Haemostasis, 125(1), 7-11. https://doi.org/10.1055/a-2438-5671

@article{96cf50add50d494f91403dff5d5609b9,
title = "TARGET: A Major European Project Aiming to Advance the Personalised Management of Atrial Fibrillation-Related Stroke via the Development of Health Virtual Twins Technology and Artificial Intelligence",
author = "{the TARGET Consortium} and Sandra Ortega-Martorell and Ivan Olier and Mattias Ohlsson and Lip, {Gregory Y.H.} and Eva Swinnen and Bart Jansen and M Degelaen and {De Raedt}, Sylvie and Lubos Omelina",
note = "Funding Information: Given this background, the European Union, through the Horizon Europe Research Program, has funded the \u201CHealth Virtual Twins for the Personalised Management of Stroke Related to Atrial Fibrillation\u201D (TARGET) Project (grant agreement no. 101136244). TARGET's consortium involves 19 partners including universities, hospitals, companies, and a charity. The project kicked started in January 2024 under the scientific leadership of Prof. Sandra Ortega-Martorell (Principal Investigator, Liverpool John Moores University, LJMU), the methodological leadership in artificial intelligence (AI) and virtual twins of Prof. Ivan Olier (LJMU), the clinical leadership in AF and stroke of Prof. Gregory Lip (University of Liverpool), and the coordination of Prof. Mattias Ohlsson (Lund University). ",
year = "2025",
month = jan,
doi = "10.1055/a-2438-5671",
language = "English",
volume = "125",
pages = "7--11",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "1",
}